Cargando…
miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells
Radioresistance remains to be a major obstacle in the management of patients with advanced prostate cancer (PCa). We have identified a mature miR-17-3p processed from the 3′ arm of precursor miR-17, which appeared to be able to inhibit three major antioxidant enzymes located in mitochondria, i.e., m...
Autores principales: | Xu, Zhi, Zhang, Yanyan, Ding, Jiaji, Hu, Weizi, Tan, Chunli, Wang, Mei, Tang, Jinhai, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143750/ https://www.ncbi.nlm.nih.gov/pubmed/30240971 http://dx.doi.org/10.1016/j.omtn.2018.08.009 |
Ejemplares similares
-
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
por: Zhang, Yanyan, et al.
Publicado: (2018) -
miR-17* Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes
por: Xu, Yong, et al.
Publicado: (2010) -
Functional miRNAs in breast cancer drug resistance
por: Hu, Weizi, et al.
Publicado: (2018) -
miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin
por: He, Zhenhua, et al.
Publicado: (2021) -
Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
por: Tan, Chunli, et al.
Publicado: (2021)